Feed CHGCF
CH

Chugai Pharmaceutical Co., Ltd.

CHGCF · OTC

$40.00 +4.19% (+$1.61)
1M -2.05%
Market Cap ¥10.5T
P/E Ratio 22.23x
Div. Yield 3.38%
ROE 24.02%

Bulios Fair Price

$20.71

48.2% downside

Current Price

$40

Undervalued Fair Value Overvalued

According to Bulios Fair Price, CHGCF is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
6/9
Valuation
43 /100
Fair
P/E 22.23x
P/FCF 25.92x
EV/EBITDA 14.71x
Growth
54 /100
Stable
EPS growth 5.07%
Book val. growth 12.49%
Rev. growth 0.02%
Profitability
100 /100
Strong
Gross margin 71.39%
FCF margin 30.11%
Net margin 35.10%
Quality
92 /100
Excellent
ROIC 23.75%
Asset turnover 0.55x
ROE 24.02%
Debt
100 /100
Low
Debt/Equity 0.01x
Net debt/EBITDA -0.54x
Current ratio 4.35x
Stability
91 /100
Stable
Beta 0.54x
Profitable years 6
Rev. volatility 10.59%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about CHGCF
Online

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Osamu Okuda

Employees

7,872

Headquarters

Tokyo

Upcoming events

27 OCT

Earnings

Upcoming earnings report

26d
31 DEC

Ex-Dividend

Ex-dividend date

91d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.